TCL Archive Breast Cancer Funding: Shalala Approves Agreement Over Disputed $14 Million August 8, 1997
TCL Archive Trial In Metastatic Disease To Be Unblinded After Regorafenib Meets Primary Endpoint November 25, 2011
TCL Archive NCI Study Fails To Support Finding Of Excess Cancer In Utah Nuclear Fallout Areas January 23, 1987